Literature DB >> 15388987

Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3.

Katalin Karikó1, Prakash Bhuyan, John Capodici, Houping Ni, John Lubinski, Harvey Friedman, Drew Weissman.   

Abstract

RNA interference (RNAi) is a powerful method that specifically suppresses gene expression in a sequence-dependent manner whose machinery is found in organisms from fungi to mammals. Mammalian cells have developed a sequence-independent system of gene suppression often induced by viral replication that includes the recognition of double-stranded RNA (dsRNA) through Toll-like receptor 3 (TLR3) and induction of type I interferon synthesis. Interferon activates the transcription of a set of genes including dsRNA-activated protein kinase that suppresses protein synthesis and 2'-5'-oligoadenylate synthetase, which generates a product that activates RNase L to cleave RNA in a sequence-independent manner. We observed that 21-bp dsRNA, a key mediator of RNAi, not only induces sequence-specific gene suppression, but also signals TLR3 to induce type I interferon and activates sequence-independent suppression of protein synthesis and enhancement of mRNA degradation. This sequence-independent suppression was demonstrated for both an exogenously administered reporter gene as well as during the targeting of viral genes in the course of acute herpes simplex virus type I infection of keratinocytes. As TLR3 is expressed by many primary cell types and cell lines, this sequence-independent suppression should be considered in the design of experiments using small interfering RNA-mediated gene suppression. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388987     DOI: 10.1159/000079987

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  26 in total

Review 1.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

2.  X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells.

Authors:  Kate L Jones; Michael Roche; Michael P Gantier; Nasim A Begum; Tasuku Honjo; Salvatore Caradonna; Bryan R G Williams; Johnson Mak
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

3.  Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA.

Authors:  Rebecca L Jorgenson; Steven L Young; Margaret J Lesmeister; Terri D Lyddon; Michael L Misfeldt
Journal:  Hum Immunol       Date:  2005-01-07       Impact factor: 2.850

4.  Age-related macular degeneration and the other double helix. The Cogan Lecture.

Authors:  Jayakrishna Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

5.  Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.

Authors:  Angela A Alexander-Bryant; Anca Dumitriu; Christopher C Attaway; Hong Yu; Andrew Jakymiw
Journal:  J Control Release       Date:  2015-09-18       Impact factor: 9.776

6.  Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response.

Authors:  Marie-Elise Bonnet; Patrick Erbacher; Anne-Laure Bolcato-Bellemin
Journal:  Pharm Res       Date:  2008-08-16       Impact factor: 4.200

7.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

8.  Possibilities for RNA interference in developing hepatitis C virus therapeutics.

Authors:  Kristi L Berger; Glenn Randall
Journal:  Viruses       Date:  2010-08-06       Impact factor: 5.818

9.  Minimizing off-target effects by using diced siRNAs for RNA interference.

Authors:  Jason W Myers; Jen-Tsan Chi; Delquin Gong; Marci E Schaner; Patrick O Brown; James E Ferrell
Journal:  J RNAi Gene Silencing       Date:  2006-07-17

10.  Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Authors:  David H Dreyfus; S Mark Tompkins; Ramsay Fuleihan; Lucy Y Ghoda
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.